Global Sleeping Aids Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Product;

Mattress & pillows, Sleep apnea devices and Others.

By Sleep Disorders;

Insomnia, Sleep Apnea, Restless Leg Syndrome, Narcolepsy, Sleep walking, Other Sleep Disorders.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn017203135 Published Date: March, 2025 Updated Date: April, 2025

Introduction

Global Sleeping Aids Market (USD Million), 2021 - 2031

In the year 2024, the Global Sleeping Aids Market was valued at USD 70,682.77 million. The size of this market is expected to increase to USD 109,840.08 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 6.5%.

The global sleeping aids market has witnessed significant growth in recent years, driven by increasing incidences of sleep disorders and growing awareness among consumers regarding the importance of healthy sleep patterns. Sleep disorders such as insomnia, sleep apnea, and restless legs syndrome have become increasingly prevalent due to factors such as lifestyle changes, stress, and shift work. As a result, there has been a rising demand for medications and devices that can help improve sleep quality and duration.

Pharmaceuticals represent a substantial segment within the sleeping aids market, with medications ranging from prescription drugs to over-the-counter supplements aimed at promoting better sleep. These medications often target specific neurotransmitters or brain receptors to induce sleep or manage underlying causes of sleep disturbances. Additionally, the market for sleep devices has expanded, encompassing products such as continuous positive airway pressure (CPAP) machines for sleep apnea, wearable sleep trackers, and smart mattresses designed to monitor and enhance sleep quality.

Advancements in technology have played a pivotal role in the evolution of the sleeping aids market. Innovations in wearable devices and mobile applications that track sleep patterns and provide personalized sleep recommendations have gained popularity among consumers seeking non-invasive solutions. As awareness grows regarding the long-term health impacts of sleep disorders, the demand for effective and convenient sleeping aids is expected to continue rising, driving further innovation and market expansion in the coming years.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product
    2. Market Snapshot, By Sleep Disorders
    3. Market Snapshot, By Region
  4. Global Sleeping Aids Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Aging Population
        2. Increasing Stress Levels
        3. Rising Awareness about Sleep Disorders
      2. Restraints
        1. Side Effects of Medications
        2. Regulatory Constraints on Certain Ingredients
        3. Availability of Non-pharmacological Alternatives
      3. Opportunities
        1. Growing Demand in Emerging Markets
        2. Technological Advancements in Sleep Technology
        3. Increasing Investment in R&D
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Sleeping Aids Market, By Product, 2021 - 2031 (USD Million)
      1. Mattress & pillows
      2. Sleep apnea devices
      3. Others
    2. Global Sleeping Aids Market, By Sleep Disorders, 2021 - 2031 (USD Million)

      1. Insomnia

      2. Sleep Apnea

      3. Restless Leg Syndrome

      4. Narcolepsy

      5. Sleep walking

      6. Other Sleep Disorders

    3. Global Sleeping Aids Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Sanofi
      2. Merck & Co., Inc.
      3. GlaxoSmithKline plc
      4. Pfizer Inc.
      5. Eisai Co., Ltd.
      6. Takeda Pharmaceutical Company Limited
      7. Johnson & Johnson Services, Inc.
      8. Bayer AG
      9. ResMed Inc.
      10. Koninklijke Philips N.V.
  7. Analyst Views
  8. Future Outlook of the Market